Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 67 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 9 Sarcoma 6 Ovarian Neoplasms 4 Brain Neoplasms 4 Neoplasms 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 HER2-negative Breast Cancer 3 Leiomyosarcoma 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Salivary Gland Neoplasms 1 Relapsed Solid Tumors 1 Refractory Solid Tumors 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Metastatic Urothelial Cell Cancer 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Ketosis 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-negative Metastatic Breast Cancer 1

Interventions

eribulin 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brest Cancer × eribulin × Clear all

NCT07333937 2026-01-12

NETHER

Xijing Hospital

Phase 2 Not yet recruiting

Brest Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡